tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCRX Stock Latest News

BioCryst presents new real-world evidence on ORLADEYO in severe HAE
The FlyBioCryst presents new real-world evidence on ORLADEYO in severe HAE
12d ago
BCRX
BioCryst’s Strategic Advancements and Market Potential: A Buy Rating by Serge Belanger
PremiumRatings
BioCryst’s Strategic Advancements and Market Potential: A Buy Rating by Serge Belanger
14d ago
BCRX
BioCryst’s ORLADEYO Receives FDA Priority Review
PremiumCompany Announcements
BioCryst’s ORLADEYO Receives FDA Priority Review
14d ago
8K
BCRX
BioCryst announces FDA acceptance of NDA for ORLADEYO
PremiumThe Fly
BioCryst announces FDA acceptance of NDA for ORLADEYO
14d ago
BCRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
MRK
ATHE
BioCryst price target raised to $11 from $8 at Barclays
PremiumThe FlyBioCryst price target raised to $11 from $8 at Barclays
21d ago
BCRX
BioCryst price target raised to $13 from $11 at RBC Capital
Premium
The Fly
BioCryst price target raised to $13 from $11 at RBC Capital
22d ago
BCRX
BioCryst price target raised to $13 from $11 at BofA
Premium
The Fly
BioCryst price target raised to $13 from $11 at BofA
22d ago
BCRX
BioCryst’s Strong Growth Prospects: Buy Rating Backed by Orladeyo’s Success and Promising Pipeline Developments
PremiumRatings
BioCryst’s Strong Growth Prospects: Buy Rating Backed by Orladeyo’s Success and Promising Pipeline Developments
22d ago
BCRX
BioCryst Pharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
BioCryst Pharmaceuticals Reports Strong Q1 2025 Growth
22d ago
BCRX
BioCryst Pharmaceuticals Reports Record Growth and Profitability
PremiumCompany Announcements
BioCryst Pharmaceuticals Reports Record Growth and Profitability
23d ago
BCRX
Strong Growth Prospects for BioCryst’s Orladeyo Drive Buy Rating and Increased Price Target
PremiumRatings
Strong Growth Prospects for BioCryst’s Orladeyo Drive Buy Rating and Increased Price Target
23d ago
BCRX
BioCryst’s Orladeyo Surpasses Expectations: A Strong Buy Recommendation
PremiumRatingsBioCryst’s Orladeyo Surpasses Expectations: A Strong Buy Recommendation
23d ago
BCRX
Morning Movers: Skechers surges following take-private deal
Premium
The Fly
Morning Movers: Skechers surges following take-private deal
23d ago
HHH
SKX
BioCryst Reports Strong Q1 2025 Financial Performance
Premium
Company Announcements
BioCryst Reports Strong Q1 2025 Financial Performance
23d ago
8K
BCRX
BioCryst sees FY25 ORLADEYO revenue $580M-$600M
PremiumThe Fly
BioCryst sees FY25 ORLADEYO revenue $580M-$600M
23d ago
BCRX
BioCryst reports Q1 EPS 0c, consensus (5c)
PremiumThe Fly
BioCryst reports Q1 EPS 0c, consensus (5c)
23d ago
BCRX
BCRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BCRX Upcoming Earnings Report: What to Expect?
25d ago
BCRX
ARMOUR, BioCryst, Viking, Builders, Hims: Trending by Analysts
PremiumWeekend Updates
ARMOUR, BioCryst, Viking, Builders, Hims: Trending by Analysts
25d ago
ARR
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe FlyBioCryst reports inducement grants under Nasdaq listing rule
26d ago
BCRX
BioCryst appoints Frank to board of directors
Premium
The Fly
BioCryst appoints Frank to board of directors
27d ago
BCRX
BioCryst Expands Board with New Director Appointment
Premium
Company Announcements
BioCryst Expands Board with New Director Appointment
27d ago
8K
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >